Clinical Trial Update: CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1) [Phase 1]

View source ↗

Summary

Chong Kun Dang Pharmaceutical completed a Phase 1 drug-drug interaction study of CKD-396 in patients with type 2 diabetes mellitus. The trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CKD-396

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED